Author

Eik Hoffmann

Centre National de la Recherche ScientifiqueORCID 0000-0003-4224-1091Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Adeline CezardiD· 1 shared Adolfo García-Pérez· 1 shared Alain R. BaulardiD· 1 shared Alan WacquieziD· 1 shared Ambre TinardiD· 1 shared Ana Yepes· 1 shared Antoine GuilloniD· 1 shared Antoine LegrasiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adeline CezardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 27, 2026

DDU384: A new preclinical candidate for the treatment of Tuberculosis

Simon R. Green, Kirsteen I. Buchanan, Helena I. Boshoff…·Laura A. T. Cleghorn

This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.

DOI 10.64898/2026.10.26.760366

mouseexperimental assay

𝕏 PostBluesky

ImmunologyEMBO Molecular MedicinePeer-reviewedFeb 16, 2026

Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling

Adeline Cezard, Déborah Bréa, Virginie Vasseur…·Mustapha Si‐Tahar

This study identifies cis-aconitate as a dual-action antiviral and anti-inflammatory agent that reduces influenza mortality in mice by targeting viral polymerase and ERK/AKT/NF-κB signaling.

5 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky